Floatz logo

Isavuconazole

Invasive Pulmonary Aspergillosis

VicalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Invasive Pulmonary Aspergillosis cohort.

Asset / SponsorPhaseRating
AMPHOTERICIN
Vical
Phase 2B
Voriconazole
Vical
Phase 2CCC
CYCLO(-ASN-LEU-D-PHE-AL((N5-ACETYL-N5-HYDROXY-ORN)-(N5-ACETYL-N5-HYDROXY-ORN)-(N5-HYDROXY-ORN))-) . AL(III)
Vical
Phase 2CCC

Same molecule, other indications

Isavuconazole is also rated in:

systemic mycosisDormant
BB
Indicative ·
64 / 100
View asset →
aspergillosisDormant
BB
Indicative ·
64 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →